Company intelligence / Profile preview

FIOS Therapeutics

San Francisco, California, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Fios Therapeutics is an early-stage biotechnology company based in San Francisco, California, focused on the development of a programmable RNA platform. The company aims to engineer a new class of RNA-based medicines that offer improved stability, precision, and therapeutic potential compared to existing RNA technologies. Founded by Sarah Gierke, a former scientist at Genentech, and supported by venture capital firm 8VC, Fios Therapeutics is currently in the pre-clinical stage of research and development. The company's modular approach to RNA design is intended to enable the rapid creation of therapies for a wide range of diseases.

Modalities: RNA therapymRNA-based drugs
Industry: Biotech

Beyond the preview

Go deeper on FIOS Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FIOS Therapeutics.

Explore the full profile